Biochemical Characterization and Identification of Bacterial Strains
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Pasteurella Multocida Isolated from Cattle
Journal of Applied Pharmaceutical Science Vol. 3 (04), pp. 106-110, April, 2013 Available online at http://www.japsonline.com DOI: 10.7324/JAPS.2013.3419 ISSN 2231-3354 Antibiotic Susceptibility and Molecular Analysis of Bacterial Pathogen Pasteurella Multocida Isolated from Cattle Azmat Jabeen, Mahrukh Khattak, Shahzad Munir*, Qaiser Jamal, Mubashir Hussain Department of Microbiology, Kohat University of Science and Technology, Kohat, Khyber Pakhtunkhwa, Pakistan. ARTICLE INFO ABSTRACT Article history: Pasteurella multocida is a Gram negative, non motile and coccobacillus bacterium. It has 5 strains i.e. A, B, D, Received on: 01/02/2013 E and F and 16 serotypes (1-16). In present study, we analyzed Pasteurella multocida B: 2 strains, responsible Revised on: 19/02/2013 for Hemorrhagic Septicemia (HS) in cattle, on morphological/microbial, biochemical, molecular level and to Accepted on: 15/03/2013 check the antibiotic sensitivity of the Pasteurella multocida. Microbial analysis showed that while grown on Available online: 27/04/2013 Brain Heart Infusion agar plates and Blood Agar Base Medium, grayish lustrous colonies of Pasteurella multocida were observed. Gram staining showed that Pasteurella multocida are gram negative. Microscopic Key words: observations revealed it to be coccobacillus and it was non- motile. Identification was conducted by Pasteurella multocida, conventional biochemical tests and percentage identification of Analytical Profile Index was 96 %. Antibiotic Hemorrhagic Septicemia, sensitivity with different antibiotics was checked by disk diffusion method and was found resistant to Analytical Profile Index, Augmentin, Amoxicillin and Aztreonam and was more susceptible to Ceftiofur. On molecular level its DNA Antibiotic sensitivity. was extracted and was run with marker having range from 0.5 – 10 kb. -
Uncommon Pathogens Causing Hospital-Acquired Infections in Postoperative Cardiac Surgical Patients
Published online: 2020-03-06 THIEME Review Article 89 Uncommon Pathogens Causing Hospital-Acquired Infections in Postoperative Cardiac Surgical Patients Manoj Kumar Sahu1 Netto George2 Neha Rastogi2 Chalatti Bipin1 Sarvesh Pal Singh1 1Department of Cardiothoracic and Vascular Surgery, CN Centre, All Address for correspondence Manoj K Sahu, MD, DNB, Department India Institute of Medical Sciences, Ansari Nagar, New Delhi, India of Cardiothoracic and Vascular Surgery, CTVS office, 7th floor, CN 2Infectious Disease, Department of Medicine, All India Institute of Centre, All India Institute of Medical Sciences, New Delhi-110029, Medical Sciences, Ansari Nagar, New Delhi, India India (e-mail: [email protected]). J Card Crit Care 2020;3:89–96 Abstract Bacterial infections are common causes of sepsis in the intensive care units. However, usually a finite number of Gram-negative bacteria cause sepsis (mostly according to the hospital flora). Some organisms such as Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus are relatively common. Others such as Stenotrophomonas maltophilia, Chryseobacterium indologenes, Shewanella putrefaciens, Ralstonia pickettii, Providencia, Morganella species, Nocardia, Elizabethkingia, Proteus, and Burkholderia are rare but of immense importance to public health, in view of the high mortality rates these are associated with. Being aware of these organisms, as the cause of hospital-acquired infections, helps in the prevention, Keywords treatment, and control of sepsis in the high-risk cardiac surgical patients including in ► uncommon pathogens heart transplants. Therefore, a basic understanding of when to suspect these organ- ► hospital-acquired isms is important for clinical diagnosis and initiating therapeutic options. This review infection discusses some rarely appearing pathogens in our intensive care unit with respect to ► cardiac surgical the spectrum of infections, and various antibiotics that were effective in managing intensive care unit these bacteria. -
2021 ECCMID | 00656 in Vitro Activities of Ceftazidime-Avibactam and Comparator Agents Against Enterobacterales
IHMA In Vitro Activities of Ceftazidime-avibactam and Comparator Agents against Enterobacterales and 2122 Palmer Drive 00656 Schaumburg, IL 60173 USA Pseudomonas aeruginosa from Israel Collected Through the ATLAS Global Surveillance Program 2013-2019 www.ihma.com M. Hackel1, M. Wise1, G. Stone2, D. Sahm1 1IHMA, Inc., Schaumburg IL, USA, 2Pfizer Inc., Groton, CT USA Introduction Results Results Summary Avibactam (AVI) is a non-β- Table 1 Distribution of 2,956 Enterobacterales from Israel by species Table 2. In vitro activity of ceftazidime-avibactam and comparators agents Figure 2. Ceftazidime and ceftazidime-avibactam MIC distribution against 29 . Ceftazidime-avibactam exhibited a potent lactam, β-lactamase inhibitor against Enterobacterales and P. aeruginosa from Israel, 2013-2019 non-MBL carbapenem-nonsusceptible (CRE) Enterobacterales from Israel, antimicrobial activity higher than all Organism N % of Total mg/L that can restore the activity of Organism Group (N) %S 2013-2019 comparator agents against all Citrobacter amalonaticus 2 0.1% MIC90 MIC50 Range ceftazidime (CAZ) against Enterobacterales (2956) 20 Enterobacterales from Israel (MIC90, 0.5 Citrobacter braakii 5 0.2% Ceftazidime-avibactam 99.8 0.5 0.12 ≤0.015 - > 128 Ceftazidime Ceftazidime-avibactam organisms that possess Class 18 mg/L; 99.8% susceptible). Citrobacter freundii 96 3.2% Ceftazidime 70.1 64 0.25 ≤0.015 - > 128 A, C, and some Class D β- Cefepime 71.8 > 16 ≤0.12 ≤0.12 - > 16 16 . Susceptibility to ceftazidime-avibactam lactmase enzymes. This study Citrobacter gillenii 1 <0.1% Meropenem 98.8 0.12 ≤0.06 ≤0.06 - > 8 increased to 100% for the Enterobacterales Amikacin 95.4 8 2 ≤0.25 - > 32 14 examined the in vitro activity Citrobacter koseri 123 4.2% when MBL-positive isolates were removed Colistin (n=2544)* 82.2 > 8 0.5 ≤0.06 - > 8 12 of CAZ-AVI and comparators Citrobacter murliniae 1 <0.1% Piperacillin-tazobactam 80.4 32 2 ≤0.12 - > 64 from analysis. -
경추 척수 손상 환자에서 발생한 Providencia Rettgeri 패혈증 1예 조현정·임승진·천승연·박권오·이상호·박종원·이진서·엄중식 한림대학교 의과대학 내과학교실
Case Report Infection & DOI: 10.3947/ic.2010.42.6.428 Chemotherapy Infect Chemother 2010;42(6):428-430 경추 척수 손상 환자에서 발생한 Providencia rettgeri 패혈증 1예 조현정·임승진·천승연·박권오·이상호·박종원·이진서·엄중식 한림대학교 의과대학 내과학교실 A Case of Providencia rettgeri Sepsis in a Patient with Hyun-Jung Cho, Seung-Jin Lim, Seung-Yeon Chun, Cervical Cord Injury Kwon-Oh Park, Sang-Ho Lee, Jong-Won Park, Jin- Seo Lee, and Joong-Sik Eom Providencia rettgeri is a member of Enterobacteriacea that is known to cause Department of Internal Medicine, Hallym Univer- urinary tract infection (UTI), septicemia, and wound infections, especially in sity College of Medi cine, Seoul, Korea immunocompromised patients and in those with indwelling urinary catheters. We experienced a case of UTI sepsis by Providencia rettgeri in a patient with spinal cord injury. The patient had only high fever without urinary symptoms or signs after high dose intravenous methylprednisolone. The laboratory results showed leukocytosis (21,900/μL, segmented neutrophils 91.1%) and pyuria. Cefepime was given empirically and it was switched to oral trimethoprim-sulfamethoxazole because P. rettgeri was identified from blood and urine culture which was susceptible to TMP-SMX. The patient was improved clinically but P. rettgeri was not eradicated microbiologically. To the best of our knowledge, this is the first case report on sepsis caused by Providencia rettgeri in Korea. Key Words: Providencia rettgeri, Sepsis, Urinary tract infection Introduction The genus Providencia is a member of the Enterobacteriaceae family which commonly dwells in soil, water, and sewage [1, 2]. Providencia rettgeri is one of five Providencia species that is known to cause various infections, especially the Copyright © 2010 by The Korean Society of Infectious Diseases | Korean urinary tract infection (UTI) [3]. -
The LOUISIANA ANTIBIOGRAM Louisiana Antibiotic Resistance 2014
The LOUISIANA ANTIBIOGRAM Louisiana Antibiotic Trends in Antibiotic Resistance Resistance 2014 in Louisiana 2008 Zahidul Islam MBBS, MPH, Raoult C Ratard MD MPH Contributors to this report: Lauren Kleamenakis MPH, Anup Subedee MD MPH and Raoult Ratard MD MPH. This report covers bacteria causing severe human infections and the antibiotics used to treat those infections. Resistance to other antimicrobials (antivirals, antifungals and anti-parasitic drugs) are not included for lack of systematic reporting and collection of comprehensive data. Contents 1-Introduction ............................................................................................................................................... 3 1.1-Bacterial resistance to antibiotics is a major threat to human health .................................................. 3 1.2-Tracking resistance patterns is a major action in the fight against antibiotic resistance ..................... 3 2-Methods ..................................................................................................................................................... 3 2.1-Active surveillance .............................................................................................................................. 3 2.2-Antibiogram collection ....................................................................................................................... 3 2.3-Analysis .............................................................................................................................................. -
Physico-Chemical and Bacteriological Quality of Water, And
PHYSICO-CHEMICAL AND BACTERIOLOGICAL QUALITY OF WATER, AND ANTIMICROBIAL SUSCEPTIBILITY OF PATHOGENIC ISOLATES FROM SELECTED WATER SOURCES IN SAMBURU SOUTH. BY JEOPHITA JUNE MWAJUMA (B.Sc, P.G.D.E) REG. NO. I56/7341/02 DEPARTMENT OF PLANT AND MICROBIAL SCIENCES A thesis submitted in partial fulfillment of the requirements for the award of the degree of Master of Science (Microbiology) in the School of Pure and Applied Sciences, Kenyatta University April 2010 ii DECLARATION I, Jeophita June Mwajuma, declare that this thesis is my original work and has not been presented for the award of a degree in any other University or any other award. Signature…………………………………... Date………………………….. We confirm that the work reported in this thesis was carried out by the candidate under our supervision. SUPERVISORS: Prof. Paul Okemo Department of Plant and Microbial Sciences Kenyatta University Signature…………………………………... Date………………………….. Dr. Alexander Njue Department of Plant and Microbial Sciences Kenyatta University Signature…………………………………... Date………………………….. Prof. Kiplagat Kotut Department of Plant and Microbial Sciences Kenyatta University Signature…………………………………... Date………………………….. iii DEDICATION For my girls, Neema and Wema. Babies, the sky is the limit! iv Formatted: Centered, Indent: Left: 0.25", 1. ACKNOWLEDGEMENT No bullets or numbering I wish to thank my supervisors Prof. Paul Okemo, Dr. Alexander Njue and Prof. Kiplagat Kotut for their expert advice and encouragement throughout the period of this study. My gratitude also goes to Earthwatch Institute for funding my research work through the Samburu Communities, Water and Wildlife project. I also wish to thank KEMRI, Welcome Trust Laboratories Kilifi, Wamba Mission Hospital and Mombasa Polytechnic University College for providing me with laboratory space and analytical tools. -
Resistant Gram-Negative Bacteria in Urine of Pregnant Women Attending Antenatal Clinic of Mother and Child Hospital, Ondo, Nigeria
Vol. 15(5), pp. 209-216, May, 2021 DOI: 10.5897/AJMR2021.9491 Article Number: FAE2CD666760 ISSN: 1996-0808 Copyright ©2021 Author(s) retain the copyright of this article African Journal of Microbiology Research http://www.academicjournals.org/AJMR Full Length Research Paper Phenotypic and molecular characterization of multiple- resistant gram-negative bacteria in urine of pregnant women attending antenatal clinic of Mother and Child hospital, Ondo, Nigeria 1 1 2* Eunice Damilola Wilkie , Anthonia Olufunke Oluduro , Thonda Oluwakemi Abike and Chidinma Vivian Chukwudum1 1Department of Microbiology, Faculty of Sciences, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria. 2Department of Biological Sciences, Faculty of Sciences, Kings University, Odeomu, Osun State, Nigeria. Received 27 January, 2021; Accepted 12 March, 2021 Phenotypic and molecular characterization of multiple antibiotic resistant Gram-negative bacteria in urine samples of pregnant women in Mother and Child Hospital, Nigeria was reported. In the study, 407 apparently healthy pregnant women were recruited. Structured questionnaire was administered to the patients to obtain their socio-demographic information and the medical history. Urine samples were collected, processed and analysed using standard microbiological procedures. Detailed identification of the bacteria isolates was done using biochemical characterization using Bergey’s Manual of Determinative Bacteriology and Analytical Profile Index (API) Kit. The antimicrobial susceptibility testing of the bacteria isolates was carried out using the Kirby-Bauer’s disk diffusion technique. Detection of the beta lactamase resistance genes (bla CTX-M and Tet A) was done by polymerase chain reactions (PCR) with appropriate primers. The following Gram-negative bacteria were recovered comprising Pseudomonas aeruginosa 48 (34.0%), Escherichia coli 30 (21.3%), Klebsiella sp. -
Diversity and Composition of the Skin, Blood and Gut Microbiome in Rosacea—A Systematic Review of the Literature
microorganisms Review Diversity and Composition of the Skin, Blood and Gut Microbiome in Rosacea—A Systematic Review of the Literature Klaudia Tutka, Magdalena Zychowska˙ and Adam Reich * Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, 35-055 Rzeszow, Poland; [email protected] (K.T.); [email protected] (M.Z.)˙ * Correspondence: [email protected]; Tel.: +48-605076722 Received: 30 August 2020; Accepted: 6 November 2020; Published: 8 November 2020 Abstract: Rosacea is a chronic inflammatory skin disorder of a not fully understood pathophysiology. Microbial factors, although not precisely characterized, are speculated to contribute to the development of the condition. The aim of the current review was to summarize the rosacea-associated alterations in the skin, blood, and gut microbiome, investigated using culture-independent, metagenomic techniques. A systematic review of the PubMed, Web of Science, and Scopus databases was performed, according to PRISMA (preferred reporting items for systematic review and meta-analyses) guidelines. Nine out of 185 papers were eligible for analysis. Skin microbiome was investigated in six studies, and in a total number of 115 rosacea patients. Blood microbiome was the subject of one piece of research, conducted in 10 patients with rosacea, and gut microbiome was studied in two papers, and in a total of 23 rosacea subjects. Although all of the studies showed significant alterations in the composition of the skin, blood, or gut microbiome in rosacea, the results were highly inconsistent, or even, in some cases, contradictory. Major limitations included the low number of participants, and different study populations (mainly Asians). Further studies are needed in order to reliably analyze the composition of microbiota in rosacea, and the potential application of microbiome modifications for the treatment of this dermatosis. -
Burkdiff: a Real-Time PCR Allelic Discrimination Assay for Burkholderia Pseudomallei and B
BurkDiff: A Real-Time PCR Allelic Discrimination Assay for Burkholderia Pseudomallei and B. mallei Jolene R. Bowers1*, David M. Engelthaler1, Jennifer L. Ginther2, Talima Pearson2, Sharon J. Peacock3, Apichai Tuanyok2, David M. Wagner2, Bart J. Currie4, Paul S. Keim1,2 1 Translational Genomics Research Institute, Flagstaff, Arizona, United States of America, 2 Northern Arizona University, Flagstaff, Arizona, United States of America, 3 Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, 4 Menzies School of Health Research, Darwin, Australia Abstract A real-time PCR assay, BurkDiff, was designed to target a unique conserved region in the B. pseudomallei and B. mallei genomes containing a SNP that differentiates the two species. Sensitivity and specificity were assessed by screening BurkDiff across 469 isolates of B. pseudomallei, 49 isolates of B. mallei, and 390 isolates of clinically relevant non-target species. Concordance of results with traditional speciation methods and no cross-reactivity to non-target species show BurkDiff is a robust, highly validated assay for the detection and differentiation of B. pseudomallei and B. mallei. Citation: Bowers JR, Engelthaler DM, Ginther JL, Pearson T, Peacock SJ, et al. (2010) BurkDiff: A Real-Time PCR Allelic Discrimination Assay for Burkholderia Pseudomallei and B. mallei. PLoS ONE 5(11): e15413. doi:10.1371/journal.pone.0015413 Editor: Frank R. DeLeo, National Institutes of Health, United States of America Received July 26, 2010; Accepted September 12, 2010; Published November 12, 2010 Copyright: ß 2010 Bowers et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. -
New Drugs – Part Ii Jacqueline King, Pharm.D
7/7/2016 ANTIBIOTICS AND ANTIFUNGALS 2016 ANNUAL MEETING NEW DRUGS – PART II JACQUELINE KING, PHARM.D. TARA MCNULTY, CPHT, RPHT PHARMACY OPERATIONS SUPERVISOR PROJECT MANAGER UFHEALTH CANCER CENTER WELLCARE HEALTH PLANS, INC [email protected] [email protected] http://s3.amazonaws.com/readers/2010/05/28/bacteria_1.jpg 2016 ANNUAL MEETING DISCLOSURE BACTERIA • Jacqueline King, Pharm.D. • I do not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies for this continuing education activity, or any affiliation with an organization whose philosophy could potentially bias my presentation • Tara, McNulty, CPhT, RPhT • I do not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies for this continuing education activity, or any affiliation with an organization whose philosophy could potentially bias my presentation http://www.dbriers.com/tutorials/wp- content/uploads/2012/12/GramPositiveNegative21.jpg https://microbewiki.kenyon.edu/images/1/1b/Gram.jpg 2016 ANNUAL MEETING 2016 ANNUAL MEETING OBJECTIVES ANTIBIOTIC RESISTANCE • Explore new medications for the treatment of infectious diseases, including HIV • Antibiotic resistance occurs when an antibiotic has lost and Hepatitis C its ability to control or kill bacterial growth • Analyze the impact of the new agents within clinical practice • Causes of antibiotic resistance: Drugs not appropriately prescribed, not completing courses of antibiotics, • Utilize -
Characterization, Prevalance and Antimicrobial Susceptibility Pattern
International Journal of Clinical Obstetrics and Gynaecology 2018; 2(6): 31-42 ISSN (P): 2522-6614 ISSN (E): 2522-6622 © Gynaecology Journal Characterization, prevalance and antimicrobial www.gynaecologyjournal.com 2018; 2(6): 31-42 susceptibility pattern of bacterial uropathogens isolated Received: 21-09-2018 Accepted: 24-10-2018 from pregnant women at Lahore general hospital, Lahore, Pakistan Rabia Habib Institute of Molecular Biology and Biotechnology, University of Lahore, Pakistan Rabia Habib, Muhammad Danish Mehmood, Sana Noreen, Huma Anwar, Mehreen Gul, Nazia Ayub and Almas Raza Muhammad Danish Mehmood Ottoman Pharma (Immuno Division), Raiwind Road Lahore, Abstract Pakistan Urinary tract infection (UTI) is common in ladies living in developing countries which may progress to complications such as pyelonephritis and preterm delivery during pregnancy. The present study provides an Sana Noreen insight for causative agent of UTI, their prevalence in pregnant ladies and its association with age, Ottoman Pharma (Immuno metabolic disorder and gestational period. Total of 375 midstream samples were collected from pregnant Division), Raiwind Road Lahore, women, pure culture were segregated on selective media and identified through analytical profile index Pakistan (API) to evaluate prevalence of uropathogens in UTI and ASB patients. Isolated uropathogenic E. coli were further characterized by polymerase chain reaction (PCR) using specific primers for genotype cjrA, cjrB, Huma Anwar and cjrC. Among 375 midstream urine samples of pregnant women, 160 cases of UTI and ASB (≥105 Ottoman Pharma (Immuno CFU) were recorded. API analysis of such samples showed 65(40.6%), 55(34.35%) and 40(25%) of E. coli, Division), Raiwind Road Lahore, Pakistan Enterococci and Staphylococci respectively. -
Rapid Identification and Antimicrobial Susceptibility Profiling of Anaerobic Bacteria in Clinical Specimens
Egyptian Journal of Medical Microbiology, July 2012 Vol. 21, No. 3 Rapid Identification and Antimicrobial Susceptibility Profiling of Anaerobic Bacteria in Clinical Specimens *Wafaa N. El-tayab, **Fatma Alzhraa M. Gomaa *Associate Professor of Microbiology & Immunology, Faculty of Pharmacy Misr International University, Cairo, Egypt **Associate Professor of Microbiology & Immunology, Faculty of Pharmacy for girls- Al-Azhar University, Egypt ABSTRACT Objective: The aim of the current study was to evaluate the ability of API 20A, and Microscan Rapid- Anaerobe identification system to identify a spectrum of clinically significant anaerobic isolates against the gold standard conventional method. Also to determine the antimicrobial susceptibility of anaerobic isolates using different methods. Materials and Methods: Anaerobes were isolated from the different clinical specimens and all isolates were initially identified by conventional tests. Identification of isolates were made also by using the API 20A and Microscan systems. Antimicrobial susceptibility of all isolates were determined by disc diffusion and broth-disk method and compared to MIC determined by broth dilution method. Results: A total of 51 isolates were recovered from clinical specimens. API 20A and Microscan correctly identified 70.6% and 82.4% of strains to species level respectively. Eight strains were misidentified by API 20A and 9 were misidentified by Microscan. B. fragilis group isolates were the most encountered clinically significant isolates among the gram-negative anaerobes. Penicillin and ampicillin had poor activity against B. fragilis group, Prevotella spp. Eubacterium spp. and Veillonella spp. Members of the B. fragilis group were more resistant to cefoxitin, than other anaerobes (66.6%). Resistance to clindamycin varied among the species range from 11.1% to 50%.